APTIMA® Trichomonas vaginalis, a transcription-mediated amplification assay for detection of Trichomonas vaginalis in urogenital specimens

Expert Review of Molecular Diagnostics

Volumn 11, Issue 7, 2011, Pages 679-688

  Chapin, Kimberle ^a,b   Andrea, Sarah ^a  

^a RHODE ISLAND HOSPITAL   (United States)

^b BROWN UNIVERSITY   (United States)

Author keywords

APTIMA Trichomonas vaginalis assay; diagnostic test; nucleic acid amplification test; sensitivity; specificity; transcription mediated amplification; Trichomonas vaginalis; trichomoniasis; vaginitis

Indexed keywords

RIBOSOME RNA;

APTIMA TRICHOMONAS VAGINALIS ASSAY; ARTICLE; BD AFFIRM VPIII; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; ENDOMETRITIS; EPIDIDYMITIS; FEMALE; FEMALE INFERTILITY; GENETIC TRANSCRIPTION; HUMAN; INFECTION RISK; MALE; MALE INFERTILITY; NUCLEIC ACID AMPLIFICATION; OSOM TRICHOMONAS RAPID TEST; PROSTATE CANCER; PROSTATITIS; QUALITATIVE ANALYSIS; SENSITIVITY AND SPECIFICITY; SEXUALLY TRANSMITTED DISEASE; TRICHOMONIASIS; URETHRITIS; URINALYSIS; UTERINE CERVICITIS; UTERINE CERVIX DYSPLASIA; UTERINE CERVIX EROSION; VAGINA SECRETION; VAGINITIS;

FEMALE; HUMANS; NUCLEIC ACID AMPLIFICATION TECHNIQUES; REAGENT KITS, DIAGNOSTIC; REPRODUCIBILITY OF RESULTS; RISK; SENSITIVITY AND SPECIFICITY; TRANSCRIPTION, GENETIC; TRICHOMONAS VAGINALIS; TRICHOMONAS VAGINITIS; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION; UROGENITAL SYSTEM;

EID: 80052776734     PISSN: 14737159     EISSN: 17448352     Source Type: Journal    
DOI: 10.1586/erm.11.53     Document Type: Article

References (60)

1. World Health Organization (WHO).Global prevalence and incidence of selected surable sexually transmitted infections: overview and estimates. WHO, Geneva, Switzerland (2001).
2. American College of Obstetricians and Gynecologists, (ACOG).ACOG practice bulletin no. 72: vaginitis. Obstet. Gynecol. 107, 1195-1206 (2006).
3. Miller W, Swygard H, Hobbs MM et al. The prevalence of trichomoniasis in young adults in the United States. Sex. Transm. Dis. 32(10), 593-598 (2005). (Pubitemid 41429179)
4. Freeman AH, Katz KA, Pandori MW et al. Prevalence and correlates of Trichomonas vaginalis among incarcerated persons assessed using a highly sensitive molecular assay. Sex. Transm. Dis. 37(3), 165-168 (2010).
5. Sutcliffe S, Newman SB, Hardick A, Gaydos C. Prevalence and correlates of Trichomonas vaginalis infection among female US federal prison inmates. Sex. Transm. Dis. 37(9), 585-590 (2010).
6. Piperaki E-T, Theodora M, Mendris M et al. Prevalence of Trichomonas vaginalis infection in women attending a major gynaecological hospital in Greece: a cross-sectional study. J. Clin. Pathol. 63(3), 249-253 (2010).
7. Krashin JW, Koumans EH, Bradshaw-Sydnor AC et al. Trichomonas vaginalis prevalence, incidence, risk factors and antibiotic-resistance in an adolescent population. Sex. Transm. Dis. 37(7), 440-444 (2009).
8. Gaydos C, Hsieh Y-H, Barnes M et al. Trichomonas vaginalis infection in women who submit self-obtained vaginal samples after internet recruitment. Sex. Transm. Dis. (2011) (In press).
9. Sutton M, Sternberg M, Koumans EH, McQuillan G, Berman S, Markowitz LE. The prevalence of Trichomonas vaginalis infection among reproductive-age women in the United States, 2001-2004 Clin. Infect. Dis. 45(10), 1319-1326 (2007). (Pubitemid 351411908)
10. Schwebke J, Hobbs M, Taylor S et al. Molecular testing for Trichomonas vaginalis in women: results from a prospective US clinical trial. J Clin. Microbiol. (In press) (2011).
11. Hobbs MM, Lapple DM, Lawing LF et al. Methods for detection of Trichomonas vaginalis in the male partners of infected women: implications for control of trichomoniasis. J. Clin. Pathol. 44(11), 3994-3999 (2006). (Pubitemid 44737241)
12. Nye MB, Schwebke JR, Body BA. Comparison of APTIMA Trichomonas vaginalis transcription-mediated amplification to wet mountmicroscopy, culture, and polymerase chain reaction for diagnosis of trichomoniasis in men and women. Am. J. Obstet Gynecol. 200(2), 188 e1-188e7 (2009).
13. Weberman B, Rosenberg SK. Evaluation of Gen-Probe Trichomonas vaginalis analyte specific reagent in urine specimens collected from male and female clients in a public health sexually transmitted disease clinic. Presented at: American Society of Microbiology 110th Annual Meeting. San Diego, CA, USA, 23-27 May 2010 (Abstract: 10-GM-A-2639-ASM).
14. Joyner J, Douglas JJ, Ragsdale S, Foster M, Judson F. Comparative prevalence of infection with Trichomonas vaginalis among men attending a sexually transmitted diseases clinic. Sex. Transm. Dis. 27(4), 236-240 (2000). (Pubitemid 30210803)
15. Andrea SB, Chapin KC. Comparison of APTIMA® Trichomonas vaginalis transcription-mediated amplification assay and BD Affirm VPIII for detection of Trichomonas vaginalis in symptomatic women: performance parameters and epidemiologic implications. J. Clin. Microbiol. 49(3), 866-869 (2011).
16. Anderson MR, Karasz A. How do clinicians manage vaginal complaints? An internet survey. MedGenMed. 7(2), 61 (2005).
17. Schwiertz A, Taras D, Rusch K, Rusch V. Throwing the dice for the diagnosis of vaginal complaints? Ann. Clin. Microbiol. Antimicrob. 5, 4 (2006).
18. Cevahir N, Kaleli I, Kaleli B. Evaluation of direct microscopic examination, acridine orange staining and culture methods for studies of Trichomonas vaginalis in vaginal discharge specimens. Mikrobiyol. Bul. 36(3-4), 329-335 (2002). (Pubitemid 36701977)
19. Centers for Disease Control and Prevention (CDC).Sexually Transmitted Diseases Treatment Guidelines, 2010 MMWR 59(RR-12), 58-61 (2010).
20. Stark JR, Judson G, Alderete JF et al. Prospective study of Trichomonas vaginalis infection and prostate cancer incidence and mortality: physicians' health study. J. Natl Cancer Inst.101, 1-6 (2009).
21. Francis SC, Kent CK, Klausner JD et al. Prevalence of rectal Trichomonas vaginalis and mycoplasma genitalium in male patients at the San Francisco STD clinic. 2005-2006 Sex. Transm. Dis. 35(9), 797-800 (2006).
22. Gardner WJ, Culberson D, Bennett B. Trichomonas vaginalis in the prostate gland. Arch. Pathol. Lab. Med. 110(5), 430-432 (1986). (Pubitemid 16104279)
23. Krieger J. Consider diagnosis and treatment of trichomoniasis in men. Sex. Transm. Dis. 27(4), 241-242 (2000). (Pubitemid 30210804)
24. Fichorova R. Impact of T. vaginalis infection on innate immune responses and reproductive outcome. J. Reprod. Immunol. 83(1-2), 185-189 (2009).
25. Chesson H, Blandford J, Gift T, Tao G, Irwin K. The estimated direct medical cost of sexually transmitted diseases among American youth, 2000 Perspect. Sex. Reprod. Health 36(1), 11-19 (2004). (Pubitemid 38252839)
26. Chesson H, Blandford J, Pinkerton S. Estimates of the annual number and cost of new HIV infections among young women attributable to trichomoniasis in the United States. Sex. Transm. Dis. 31(9), 547-551 (2004). (Pubitemid 39122137)
27. Fuller DD, Buckner R, Newcomer K, Brunnemer C, O'Brien D, Davis TE. Comparison of APTIMA analyte specific reagents to wet mount, culture, Affirm VPIII, and OSOM trichomonas rapid test for detection of Trichomonas vaginalis fromvaginal swabs & cytyc thinprep vials. Presented at: 18th International Society for Sexually Transmitted Diseases Research. London, UK, 28 June-1 July 2009 (Poster P-151).
28. Huppert J, Mortensen J, Reed J et al. Rapid antigen testing compares favorably with transcription-mediated amplification assay for the detection of Trichomonas vaginalis in young women. Clin. Infect. Dis. 45(2), 194-198 (2007). (Pubitemid 47041010)
29. Rich K, Huppert J, Mortensen J et al. Comparison of transcription- mediated amplification, rapid anitgen test, culture, and wet mount for detection of trichomonas vaginalis in female adolescents. Presented at: 18th International Society for Sexually Transmitted Diseases Research. London, UK, 28 June-1 July 2009 (Poster P-137).
30. Sitay A, Bungo J, Dickey K et al. Rapid detection of Trichomonas vaginalis from vaginal specimens by transcription-mediated amplification. Presented at: American Society for Microbiology Meeting. Washington, DC, USA 18-22 May 2003
31. Lara-Torre E, Pinkerton J. Accuracy of detection of Trichomonas vaginalis organisms on a liquid-based papanicolaou smear. Am. J. Obstet. Gynecol. 188(2), 354-356 (2003). (Pubitemid 36249970)
32. Ohlemeyer C, Hornberger L, Lynch D, Swierkosz E. Diagnosis of Trichomonas vaginalis in adolescent females: InPouch TV culture versus wet-mount microscopy. J. Adolesc. Health 22(3), 205-208 (1998). (Pubitemid 28110168)
33. Levi M, Torres J, Pina C, Klein R. Comparison of the InPouch TV culture system and Diamond's modified medium for detection of Trichomonas vaginalis. J. Clin. Microbiol. 35(12), 3308-3310 (1997). (Pubitemid 27505767)
34. Chapin KC, Andrea SB, Seadale ML, Roberts MB, Nijhawan AE, Clarke JG. Comparison of the APTIMA Trichomonas (ATV) analyte-specific-reagents and InPouch culture methods for dection of Trichomonas vaginalis in incarcerated women. Presented at: 110 ASM General Meeting. San Diego, CA, USA, 23-27 May 2010
35. Getman D, Davis I P, Bankowski M et al. Comparison of transcription-mediated amplification, culture and PCR methods for detection of Trichomonas vaginalis. Presented at: Scheveningen Molecular Meeting. Scheveningen, The Netherlands, 13-14 October 2005
36. Campbell L, Woods V, Lloyd T, Elsayed S, Church D. Evaluation of the OSOM Trichomonas rapid test versus wet preparation examination for detection of Trichomonas vaginalis vaginitis in specimens from women with a low prevalence of infection. J. Clin. Microbiol. 46(10), 3467-3469 (2008).
37. Huppert J, Batteiger BE, Braslins P et al. Use of immunochromatographic assay for rapid detection of Trichomonas vaginalis in vaginal specimens. J. Clin. Microbiol. 43(2), 684-687 (2005). (Pubitemid 40256019)
38. Andrea SB, Chapin KC. Comparison of APTIMA® Trichomonas vaginalis transcription-mediated amplification assay and BD Affirm VPIII for detection of Trichomonas vaginalis in symptomatic women: Performance parameters and epidemiologic implications. J. Clin. Microbiol. 49(3), 866-869 (2011).
39. Schwebke JR. Update of trichomoniasis. Sex. Transm. Infect. 78(5), 378-379 (2002). (Pubitemid 35177069)
40. Wendel K, Erbelding E, Gaydos C, Rompalo A. Use of urine polymerase chain reaction to define the prevalence and clinical presentation of Trichomonas vaginalis in men attending an STD clinic. Sex. Transm. Dis. 79(2), 151-153 (2003). (Pubitemid 36469623)
41. Hardick A, Hardick J, Wood BJ, Gaydos C. Comparison between the Gen-Probe transcription-mediated amplification Trichomonas vaginalis research assay and real-time PCR for Trichomonas vaginalis detection using a roche lightcycler instrument with female self-obtained vaginal swab samples and male urine samples. J. Clin. Microbiol. 44(11), 4197-4199 (2006). (Pubitemid 44737270)
42. Clarke JG, Nijhawan AE, Seadale ML, Salloway R, Chapin KC. Acceptability of routine Trichomonas screening for incarcerated women. Presented at: American Public Health Association 138 Annual Meeting. Denver, CO, USA, 6-10 November 2010
43. Chapin KC, Andrea SB, Florczyk J, Kojic E. Comparison of transcription mediated amplification (TMA) and polymerase chain reaction (PCR) methods for detection of Trichomonas vaginalis from SUN study patients. Presented at: 2010 CDC STD Prevention Conference. Atlanta, GA, USA, 8-11 March 2010
44. Van Der Pol B, Kraft C, Williams J. Use of an adaption of a commercially available PCR assay aimed at diagnosis of chlamydia and gonorrhea to detect Trichomonas vaginalis in urogenital specimens. J. Clin. Microbiol. 44(2), 366-373 (2006). (Pubitemid 43222224)
45. Caliendo AM, Jordan J, Green A, Ingersoll J, Diclemente RJ, Wingwood GM. Real-time PCR improves detection of Trichomonas vaginalis infection compared with culture using self-collected vaginal swabs. Infect. Dis. Obstet. Gynecol. 13(3), 145-150 (2005). (Pubitemid 41445025)
46. Chernesky MA, Jang D, Luinstra K et al. High analytical sensitivity and low rates of inhibition may contribute to detection of Chlamydia trachomatis in significantly more women by the APTIMA combo 2 assay. J. Clin. Microbiol. 44(2), 400-405 (2006). (Pubitemid 43222230)
47. Munson E, Napierala M, Olson R et al. Impact of Trichomonas vaginalis transcription-mediated amplification-based analyte-specific-reagent testing in a metropolitan setting of high sexually transmitted disease prevalence. J. Clin. Microbiol. 46(10), 3368-3374 (2008).
48. Hollman D, Coupey S, Fox A, Herold B. Screening for Trichomonas vaginalis in high-risk adolescent females with a new transcription-mediated nucleic acid amplification test (NAAT): associations with ethnicity, symptoms, and prior and current STIs. J. Pediatr. Adolesc. Gynecol. 23(5), 312-316 (2010).
49. Girardet RG, Lahoti S, Howard LA et al. Epidemiology of sexually transmitted infections in suspected child victims of sexual assault. Pediatrics 124(1), 79-86 (2009).
50. Heine P, McGregor J. Trichomonas vaginalis: a reemerging pathogen. Clin. Obstet. Gynecol. 36(1), 137-144 (1993). (Pubitemid 23065139)
51. Mann JR, McDermott S, Barnes TL, Hardin J, Bao H, Zhou L. Trichomoniasis in pregnancy and mental retardation in children. Ann Epidemiol. 19, 891-899 (2009).
52. Moodley P, Wikinson D, Connolly C, Moodley J, Sturm A. Trichomonas vaginalis is associated with pelvic inflammatory disease in women infected with human immunodeficiency virus. Clin. Infect. Dis. 34(4), 519-522 (2002).
53. Burstein G, Zenilman J. Nongonococcal urethritis-a new paradigm. Clin. Infect. Dis. 28(1), 66-73 (1999).
54. Cotch MF, Pastorek JGI, Nugent RP et al. Trichomonas vaginalis associated with low birth weight and preterm delivery. Sex. Transm. Dis. 24(6), 353-360 (1996).
55. Zhang Z, Begg C. Is Trichomonas vaginalis a cause of cervical neoplasia? Results from a combined analysis of 24 studies. Int. J. Epidemiol. 23(4), 682-690 (1994). (Pubitemid 24260366)
56. Shew ML, Fortenberry JD, Tu W et al. Association of condom use, sexual behaviors, and sexually transmitted infections with the duration of genital human papillomavirus infection among adolescent women. Arch. Pediatr. Adolesc. Med. 160, 151-156 (2006). (Pubitemid 43213859)
57. Madhivanan P, Krupp K, Chandrasekaran V et al. Prevalence and correlates of bacterial vaginosis among young women of reproductive age in Mysore, India. Indian J. Med. Microbiol. 26(2), 132-137 (2008). (Pubitemid 351652293)
58. Thurman A, Doncel G. Innate immunity and inflammatory response to Trichomonas vaginalis and bacterial vaginsosis: relationship to HIV acquisition. Am. J. Reprod. Immunol. 65(2), 89-98 (2011).
59. Kissinger P, Amedee A, Clark RA et al. Trichomonas vaginalis treatment reduces vaginal HIV-1 shedding. Sex. Tranm. Dis. 36(1), 11-16 (2009).
60. Depuydt C, Leuridan E, Van Damme P, Bogers J, Vereecken A, Donders G. Epidemiology of Trichomonas vaginalis and human papillomavirus infection detected by real-time PCR in Flanders. Gynecol. Obstet. Invest. 70(4), 273-280 (2010).